11th May 2015 3:00 pm |
RNS |
Presenting at BAML 2015 Healthcare Conference |
11th May 2015 12:00 pm |
RNS |
Half Yearly Report |
11th May 2015 12:00 pm |
RNS |
Initiates Ph3 Pivotal Study of Epidiolex in LGS |
11th May 2015 11:45 am |
RNS |
Holding(s) in Company |
11th May 2015 11:45 am |
RNS |
Holding(s) in Company |
8th May 2015 4:22 pm |
RNS |
Holding(s) in Company |
6th May 2015 12:00 pm |
RNS |
Notice of Results |
6th May 2015 12:00 pm |
RNS |
Initiates Phase 2 Trial of CBDV in Epilepsy |
6th May 2015 7:01 am |
RNS |
Closing of U.S. Public Offering of ADSs |
1st May 2015 3:28 pm |
RNS |
Holding(s) in Company |
1st May 2015 7:30 am |
RNS |
Holding(s) in Company |
29th Apr 2015 7:00 am |
RNS |
Pricing of U.S. Public Offering of ADSs |
28th Apr 2015 7:00 am |
RNS |
Proposed Public Offering of ADSs |
27th Apr 2015 12:00 pm |
RNS |
US Patent Allowance for Use of Cannabidivarin |
24th Apr 2015 12:00 pm |
RNS |
Orphan Drug Designation for CBD in NHIE |
23rd Apr 2015 7:00 am |
RNS |
New Physician Reports of Epidiolex Treatment |
21st Apr 2015 12:00 pm |
RNS |
Starts 2nd Ph 3 Epidiolex Trial in Dravet Syndrome |
14th Apr 2015 7:00 am |
RNS |
New Epidiolex Data Released by AAN |
1st Apr 2015 2:03 pm |
RNS |
Holding(s) in Company |
31st Mar 2015 12:00 pm |
RNS |
Starts Ph 3 Trial for Epidiolex in Dravet Syndrome |
17th Mar 2015 5:18 pm |
RNS |
Holding(s) in Company |
17th Mar 2015 5:15 pm |
RNS |
Holding(s) in Company |
25th Feb 2015 12:00 pm |
RNS |
Presenting at Upcoming Investor Conferences |
17th Feb 2015 3:25 pm |
RNS |
Blocklisting Interim Review |
16th Feb 2015 3:52 pm |
RNS |
Holding(s) in Company |
16th Feb 2015 3:48 pm |
RNS |
Holding(s) in Company |
9th Feb 2015 5:31 pm |
RNS |
Director/PDMR Shareholding |
5th Feb 2015 2:25 pm |
RNS |
Result of AGM |
5th Feb 2015 12:00 pm |
RNS |
Presents at Leerink Global Healthcare Conference |
4th Feb 2015 12:01 pm |
RNS |
1st Quarter Results |
27th Jan 2015 7:01 am |
RNS |
Notice of Results |
9th Jan 2015 4:24 pm |
RNS |
Block Listing Application |
8th Jan 2015 12:00 pm |
RNS |
Update on Epidiolex Program |
8th Jan 2015 12:00 pm |
RNS |
Results in Sativex Phase 3 Cancer Pain Trial |
22nd Dec 2014 7:00 am |
RNS |
GW Added to NASDAQ Biotechnology Index |
17th Dec 2014 6:16 pm |
RNS |
Publication of UK Annual Report and Accounts |
17th Dec 2014 4:49 pm |
RNS |
Director/PDMR Shareholding |
3rd Dec 2014 8:22 am |
RNS |
Holding(s) in Company |
2nd Dec 2014 12:00 pm |
RNS |
Final Results |
26th Nov 2014 7:00 am |
RNS |
GW Presents at Piper Jaffray Healthcare Conference |